Schizophrenia is a chronic disabling disease which in the majority of cases requires long-term treatment with antipsychotic medication. Before the development of atypical antipsychotics, treatment choice was restricted to conventional (or typical) antipsychotics, which are known to cause a range of side effects including extrapyramidal symptoms. Although atypical agents provide a favourable alternative (advocated by the National Institute of Clinical Excellence in the UK), they are associated...Expand abstract
- Publication status:
- Publisher copy:
- Copyright date:
Aripiprazole in schizophrenia: consensus guidelines.
If you are the owner of this record, you can report an update to it here: Report update to this record